Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR)
CUSIP: 86366E106
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Ordinary Shares, par value $0.0001 per share
- Shares outstanding
- 213,001,347
- Total 13F shares
- 54,653,188
- Share change
- -1,341,803
- Total reported value
- $1,133,630,623
- Put/Call ratio
- 76%
- Price per share
- $20.74
- Number of holders
- 172
- Value change
- -$12,998,783
- Number of buys
- 99
- Number of sells
- 59
Quarterly Holders Quick Answers
What is CUSIP 86366E106?
CUSIP 86366E106 identifies GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 86366E106:
Top shareholders of GPCR - Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital Research Global Investors |
13D/G
13F
|
Company |
3.8%
|
6,492,435
|
$168,218,991 | $0 | 31 Mar 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
3.7%
|
7,791,183
|
$134,865,377 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
2.8%
|
5,883,707
|
$101,846,967 | — | 31 Mar 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
2%
|
4,355,194
|
$86,126,811 | — | 31 Mar 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
1.9%
|
4,100,000
|
$70,971,000 | — | 31 Mar 2025 | |
| Vestal Point Capital, LP |
13F
|
Company |
0.84%
|
1,788,990
|
$30,967,417 | — | 31 Mar 2025 | |
| BVF INC/IL |
13F
|
Company |
0.83%
|
1,771,417
|
$30,663,228 | — | 31 Mar 2025 | |
| Capital International Investors |
13F
|
Company |
0.76%
|
1,619,026
|
$28,025,340 | — | 31 Mar 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
0.71%
|
1,517,418
|
$26,266,506 | — | 31 Mar 2025 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.7%
|
1,481,809
|
$25,650,112 | — | 31 Mar 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.6%
|
1,272,743
|
$22,031,181 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.55%
|
1,170,948
|
$20,269,110 | — | 31 Mar 2025 | |
| FIL Ltd |
13F
3/4/5
|
Company · Other* |
0.54%
|
1,150,440
|
$19,914,117 | — | 31 Mar 2025 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.53%
|
1,132,979
|
$19,611,866 | — | 31 Mar 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
0.5%
|
1,063,000
|
$18,400,530 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.47%
|
992,340
|
$17,177,405 | — | 31 Mar 2025 | |
| Ramy Farid |
3/4/5
|
Director |
—
mixed-class rows
|
3,535,495
mixed-class rows
|
$17,176,500 | — | 07 Feb 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.37%
|
790,159
|
$13,677,652 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.36%
|
777,173
|
$13,453,000 | — | 31 Mar 2025 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.36%
|
756,707
|
$13,098,598 | — | 31 Mar 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.35%
|
740,152
|
$12,812,023 | — | 31 Mar 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.33%
|
704,864
|
$12,201,196 | — | 31 Mar 2025 | |
| Casdin Capital, LLC |
13F
|
Company |
0.33%
|
700,000
|
$12,117,000 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.33%
|
692,439
|
$11,986,120 | — | 31 Mar 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.31%
|
652,028
|
$11,286,605 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.27%
|
566,505
|
$9,806,203 | — | 31 Mar 2025 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.24%
|
510,201
|
$8,831,601 | — | 31 Mar 2025 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
0.23%
|
481,241
|
$8,330,282 | — | 31 Mar 2025 | |
| Logos Global Management LP |
13F
|
Company |
0.2%
|
425,000
|
$7,356,750 | — | 31 Mar 2025 | |
| Foresite Capital Management VI LLC |
13F
|
Company |
0.2%
|
420,000
|
$7,270,200 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.19%
|
394,386
|
$6,826,822 | — | 31 Mar 2025 | |
| Handelsbanken Fonder AB |
13F
|
Company |
0.18%
|
380,000
|
$6,578,000 | — | 31 Mar 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.18%
|
373,407
|
$6,463,675 | — | 31 Mar 2025 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.17%
|
361,565
|
$6,258,690 | — | 31 Mar 2025 | |
| HSG Holding Ltd |
13F
|
Company |
0.12%
|
266,062
|
$6,204,566 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.15%
|
324,435
|
$5,615,970 | — | 31 Mar 2025 | |
| Camber Capital Management LP |
13F
|
Company |
0.14%
|
300,000
|
$5,193,000 | — | 31 Mar 2025 | |
| Monashee Investment Management LLC |
13F
|
Company |
0.14%
|
292,862
|
$5,069,441 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.12%
|
264,085
|
$4,571,311 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
0.12%
|
248,899
|
$4,308,442 | — | 31 Mar 2025 | |
| ArrowMark Colorado Holdings LLC |
13F
|
Company |
0.12%
|
245,186
|
$4,244,170 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
238,197
|
$4,123,190 | — | 31 Mar 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.11%
|
229,431
|
$3,971,451 | — | 31 Mar 2025 | |
| Bellevue Group AG |
13F
|
Company |
0.1%
|
221,715
|
$3,837,887 | — | 31 Mar 2025 | |
| S.c.a. Candriam |
13F
|
Individual |
0.1%
|
214,063
|
$3,705,431 | — | 31 Mar 2025 | |
| Pier Capital, LLC |
13F
|
Company |
0.1%
|
212,520
|
$3,678,721 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.1%
|
202,483
|
$3,504,981 | — | 31 Mar 2025 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.09%
|
188,069
|
$3,255,474 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.08%
|
175,424
|
$3,036,589 | — | 31 Mar 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.08%
|
168,553
|
$2,917,652 | — | 31 Mar 2025 |
Institutional Holders of Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) as of Q2 2025
As of 30 Jun 2025,
Structure Therapeutics Inc. - Ordinary Shares, par value $0.0001 per share (GPCR) was held by
172 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,653,188 shares.
The largest 10 holders included
WELLINGTON MANAGEMENT GROUP LLP, Deep Track Capital, LP, FMR LLC, JANUS HENDERSON GROUP PLC, BAKER BROS. ADVISORS LP, BVF INC/IL, Capital International Investors, AMERIPRISE FINANCIAL INC, RA CAPITAL MANAGEMENT, L.P., and CITADEL ADVISORS LLC.
This page lists
172
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
150
Q2 2025 holders
172
Holder diff
22
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.